BACKGROUND: Studies of the relationship between patient self-reported angina symptoms using the Seattle Angina Questionnaire (SAQ) and angiographic findings after coronary artery bypass grafting surgery (CABG) are lacking. Nested within a randomized controlled trial, this prospective observational cohort comparison study aimed to assess which clinical characteristics and angiographic findings are associated with selfreported angina 1 year after CABG.
T he therapeutic goals of coronary artery grafting bypass surgery (CABG) for patients with stable ischemic heart disease are to prolong survival and improve health status including symptoms, function, and quality of life. 1 In patients with advanced coronary artery disease, completeness of revascularization is increasingly being recognized as important in improving patients' clinical and health status outcomes. 2, 3 However, it is recognized that CABG in and of itself may not result in sustained reperfusion of patients' myocardium because of either incomplete initial revascularization, early graft failure, new stenoses in the native coronary arteries distal to graft insertion, or new lesions in arteries that were not bypassed. To our knowledge, the inclusion of routine 1-year post-CABG angiographic findings into models predicting post-CABG self-reported disease-specific health status has not been studied and could be important in understanding the relationship between sustained revascularization and symptoms after CABG.
Funded by the Department of Veterans Affairs Cooperative Studies Program, the ROOBY trial (Randomized On/Off Pump Bypass) was a multicenter prospective study of 2203 patients randomized to on-pump versus off-pump CABG. 4 Prespecified components of the study included that patients undergo a study-directed coronary angiogram at their 1-year end of study visit, as well as complete health-related quality-of-life surveys, including the Seattle Angina Questionnaire (SAQ). 4 The objectives of this ROOBY trial subanalysis were to identify clinical predictors of self-reported angina after CABG and evaluate whether there was any association between routine post-CABG angiographic findings and self-reported angina.
METHODS

Transparency and Openness Promotion Guidelines
The data, analytic methods, and study materials will not be made available to other researchers for the purposes of reproducing the results at this time. Veterans Affairs regulations require that the study be 7 years beyond study closure, including all analyses, before the results can be released to outside investigators. However, the detailed analytic methods (eg, SAS summary reports) supporting this ROOBY trial subanalysis will be made available on written request. 
Ethics and Compliance
One-Year Post-CABG Coronary Angiography
The ROOBY trial prespecified that patients undergo a 1-year follow-up coronary angiogram. The methods of the angiographic core laboratory assessments have been published previously. 5 Briefly, study patients underwent 1-year post-CABG coronary angiography unless the patient refused, was not able to return for the follow-up visit, or there was a contraindication to coronary angiography such as creatinine >2.0 mg/dL. All baseline and 1-year coronary angiograms were scored by the core laboratory, which was blinded to treatment assignment. The coronary artery tree was subdivided into segments per the Bypass Angioplasty Revascularization Investigation modification of the American College of Cardiology/American Heart Association criteria. 6 Percentage stenosis was calculated by comparing the narrowest diameter of a lesion in any view to the most normal proximal or distal reference segment in the same frame. An artery with a reference diameter ≥1.5 mm and a >50% diameter narrowing of a diseased segment was considered to have a clinically significant stenosis. 6 At 1-year angiography, bypass grafts were evaluated for patency (open versus closed) and for FitzGibbon classification in which FitzGibbon A designates an excellent/unimpaired graft, B designates an impaired graft with a stenosis >50% reducing the caliber of the graft to <50% of the target artery diameter, and O designates a completely occluded graft. Grafts with a string sign but still patent were classified as FitzGibbon B.
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WHAT IS KNOWN
• Coronary artery bypass grafting surgery (CABG) carries a class I recommendation for improvement in symptoms in patients with significant coronary artery disease who have ongoing angina despite guideline-directed medical therapy.
• No studies have examined whether post-CABG angiographic findings correlate with patient selfreported angina after CABG.
WHAT THE STUDY ADDS
• This large study of 1258 patients confirms that younger age, worse self-reported baseline angina, smoking, diabetes mellitus, and depression are all significantly associated with post-CABG angina.
• Of these, depression is the strongest predictor with an odds ratio of 1.97.
• The only significantly associated 1-year post-CABG angiographic finding was effective revascularization of the left anterior descending territory, which had an odds ratio of 0.59 for angina.
The 3 primary coronary regions consisting of the left anterior descending (LAD), circumflex, and right coronary artery territories were evaluated using prespecified criteria. Each coronary region was scored as effectively revascularized (ER) when FitzGibbon A patent grafts supplied the major diseased artery within the territory, each graft was appropriately anastomosed distal to the primary stenosis, and there were no new significant coronary lesions within 1 cm distal to the graft anastomosis. For example, if the 1-year coronary angiogram revealed an LAD artery with a 90% proximal lesion and a widely patent internal mammary artery graft to the mid-LAD with no new anastomotic lesions, then the LAD territory was considered ER. However, if the bypass graft to the LAD was occluded, or there was a FitzGibbon A internal mammary artery graft with a new significant lesion just distal to the anastomosis, then the LAD territory was considered ineffectively revascularized. Before participating in the study, all angiographic core laboratory investigators underwent a training and validation process. Interrater reliability for graft patency (open versus closed graft), FitzGibbon classification, and ER versus ineffectively revascularized was excellent with over 98% agreement. 
Disease-Specific QoL
Study patients completed preoperative and 1-year diseasespecific quality of life (QoL) assessments using the SAQ, which assessed symptoms within the 4 weeks before completing the questionnaire. 8 The 1-year questionnaires were mailed to the patients 2 weeks before the 1-year visit, and patients were asked to complete these at home and bring the completed form to the 1-year visit. Otherwise, patients were asked to complete the SAQ the morning of the cardiac catheterization (≈10% of subjects in both groups [P=0.26] completed the SAQ the morning of the coronary angiogram). The SAQ subscale of interest to this subanalysis was the angina frequency (SAQ-AF) domain, specifically the question: Over the past 4 weeks, on average, how many times have you had chest pain, chest tightness, or angina? This subscale was chosen because the most common symptom for patients with coronary disease undergoing revascularization is angina. Although the quality-of-life domain is relevant, it is more of a distant consequence of coronary artery disease than angina itself.
Assessment of Depression
Patients also had assessments of depression, before the index study CABG, using the Beck Depression Inventory II-a validated 21-item questionnaire evaluating self-reported depression symptoms. Higher scores indicate worse symptoms with a score ≥14 considered significant depression. 
Group Comparisons
Univariate comparison of baseline variables and 1-year angiographic findings were made between patients reporting angina within the previous 4 weeks of their 1-year post-CABG visit and patients with no angina. Patients with interim coronary revascularization procedures before the 1-year visit were excluded to avoid potential bias in self-reported angina on the SAQ.
Multivariable Comparisons
Multivariable logistic regression analysis was used to assess the baseline demographic and clinical factors and 1-year angiographic findings that were univariately associated (P<0.1) with post-CABG angina. Based on literature review, variables included in univariate screening included age, smoking, diabetes mellitus, peripheral vascular disease, left ventricular function, baseline SAQ-AF score, on-pump versus off-pump surgery, number of diseased vessels pre-CABG, pre-CABG depression (Beck Depression Inventory II score ≥14), β-blocker use at 1 year, ER versus ineffectively revascularized for each coronary territory, graft occlusions, and residual coronary lesions ≥70% in native coronary arteries, that were either unbypassed or supplied by an occluded graft.
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Statistical Analysis
Baseline characteristics and end points were compared using Fisher exact tests, χ 2 techniques, t tests, or Kruskal-Wallis tests as appropriate. Per trial protocol, P≤0.01 was used to determine statistical significance for bivariate comparisons, and P<0.05 was used for the multivariable logistic regression analysis. Data collection and statistical analysis were performed by the Veterans Affairs Cooperative Studies Program Coordinating Center at Perry Point, Maryland, using SAS, version 9.4.
RESULTS
Of the 2203 patients randomized to on-pump or offpump CABG in the ROOBY study, 1258 (57%) completed routine study-specified follow-up coronary angiography at 1-year and a 12-month SAQ (Figure 1 ). The primary reasons for exclusion (>1 reason was possible) included patient had an interim angiogram but no 12-month study (n=36), patient was revascularized before the 12-month angiogram creating potential bias in self-reported angina on the SAQ (n=54), patient did not complete the SAQ (n=377), patient refused angiography (n=628), patient died before the 1-year visit (n=70), patient had an elevated serum creatinine >2.0 (n=52), or loss to follow-up (n=47).
There were 511 ROOBY patients who completed the SAQ-AF at 1 year but did not undergo coronary angiography. There was no difference between the average SAQ-AF score in this group with no 1-year angiography versus the average SAQ-AF score in the 1258 patients who completed both the coronary angiogram and SAQ at 1 year (SAQ-AF score 91.0±15.8 versus 89.9±16.8 respectively, P=0.22). Further, there was no significant difference (P=0.12) in the rate of angina at 12 months post-CABG between the no-angiography and study groups. Among the 1258 patients in this study with complete angiographic and SAQ-AF 12-month data, 784 (62.3%) reported no angina and 474 (37.7%) had ongoing angina (daily, weekly, or monthly). The noangina group was compared with the angina group to determine the patient related factors and post-CABG angiographic findings that were associated with selfreported angina (Table) . The angina group was more likely (P <0.1 for univariate trends) than the no-angina group to be younger (average age, 60.6 versus 63.0 years; P<0.01), to be actively smoking before CABG (39.5% versus 28.0%; P<0.01), to be diabetic (44.3% versus 39.5%; P=0.09), to have a lower baseline SAQ-AF score (average score, 55.7 versus 68.5; P<0.01), and to be depressed (18.9% with moderate or severe depression in the angina group versus 7.1% in no-angina group, P<0.01). The angina group also was less likely to have 3-vessel coronary disease before CABG (P=0.06). There were no differences between angina and noangina groups in the percentage of patients with graft occlusions or the percentage of patients with residual coronary lesions of ≥70% at 1-year angiography. The only 1-year angiographic finding that was significantly different between groups was effective revascularization of the LAD territory (92.6% in no-angina group versus 87.7% in angina group, P<0.01). Revascularization status of the circumflex or the right coronary artery territories was not significantly associated with angina.
Multivariable logistic regression analysis using the univariate eligible variables (P<0.1) identified above revealed the following baseline clinical characteristics were significantly associated with a patient reporting angina 1 year after CABG: for every year increase in age, the odds ratio (OR) for angina was 0.982, P=0.0471; for every point better on the baseline SAQ-AF, the OR was 0.984, P<0.0001; current smoker OR was 1.345, P=0.0482; diabetic OR was 1.354, P=0.0296; and depression (Beck Depression Inventory II score ≥14) OR was 1.967, P<0.0001. The only 1-year angiographic finding associated with angina was ER of the LAD territory with OR of 0.586, P=0.022 (namely, if the LAD territory was well revascularized, the patient was less likely to have angina; Figure 2 ). The area under the curve of the model was 0.693.
DISCUSSION
Coronary artery bypass graft surgery has consistently been shown to produce significant improvement in disease-specific QoL ≤8 years post-CABG. [12] [13] [14] [15] [16] However, many patients continue to report angina after CABG. Studies including post-CABG angiographic findings in multivariable models to predict patient-reported angina after bypass surgery are lacking. This ROOBY study subanalysis provides a large angiographic cohort affording the opportunity to examine the relationship between disease-specific QoL using the SAQ and 1-year post-CABG angiographic findings. This study found that the only 1-year post-CABG angiographic finding associated with the freedom from angina was ER of the LAD territory. Among pre-CABG clinical characteristics, younger age, worse baseline SAQ-AF score, active smoking, diabetes mellitus, and depression were associated with self-reported angina 1 year post-CABG.
Previous studies have reported that clinical variables associated with ongoing angina after percutane- ous intervention include younger age, worse baseline SAQ-AF score, and depression. 10, 11 The results from this analysis of the ROOBY study confirm that younger age, worse baseline SAQ-AF score, and pre-CABG depression are also associated with persistent angina symptoms 1 year after CABG. This information may be useful when counseling patients on expected symptom improvement after CABG.
Pre-CABG depression was one of the most significant predictors (OR, 1.967) of self-reported angina 1 year after CABG. Other small studies have also reported that pre-CABG or early post-CABG depression predicts angina 1 to 2 years after CABG, and others have reported that preoperative depression predicts less improvement in general health-related QoL instruments after CABG. [17] [18] [19] [20] [21] The current study confirms in a large cohort that pre-CABG depression is strongly associated with self-reported post-CABG angina and appears to be as important as anatomic findings in predicting angina.
Overall, 62% of these ROOBY patients had no angina, which is comparable to the Coronary Artery Surgery Study, which reported 66% of their patients were asymptomatic 1 year after CABG. 22 Interestingly, multivariable modeling revealed that the only angiographic finding significantly associated with a patient being angina-free after CABG was ER of the LAD territory, underscoring the importance of complete revascularization of the anterior wall to improving health status outcomes. An occluded bypass graft, a nonrevascularized residual lesion ≥70% in a nonbypassed artery, and incomplete revascularization of the circumflex or right coronary territories were not significantly associated with angina symptoms. One other CABG trial has similarly reported a lack of angina symptoms in patients with angiographically documented incomplete revascularization 1 year post-CABG. In the Bypass Angioplasty Revascularization Investigation, 135 patients with CABG had 1-year follow-up angiography with only 12% reporting angina, even though 53% of these patients had a significant amount of myocardium at risk for ischemia. 23 Possible explanations for the lack of angina in patients with incomplete revascularization include lesions that appear significant angiographically but are not functionally significant, lesions supplying infarcted territories, poor activity levels, or other ischemic symptoms such as dyspnea. 23 In this study, the presence or absence of angina could not be explained by concurrent medication use because ≥90% of the patients in both groups were taking β-blockers, aspirin, and lipid-lowering medications. Theoretically, if patients in the no-angina group were taking long-acting nitrates, it could prevent ischemic symptoms despite incomplete revascularization. However, in this study, nitrate use did not account for the observed differences between groups because nitrates were prescribed rarely (8.5% of patients) in the no-angina group. Most patients in the group with self-reported angina symptoms were well revascularized (eg, 68.8% had no residual lesions ≥70%). These patients may be experiencing ischemic symptoms from small vessel disease, diffuse disease, or microvascular dysfunction or may be experiencing noncardiac chest pain. [24] [25] [26] In the Project Ex Vivo Vein Graft Engineering via Transfection IV trial, routine angiography found vein graft occlusion at 12 to 18 months post-CABG was associated with repeat revascularization but not an increased risk of death or myocardial infarction at 4 years. 27 One possible explanation for this finding is that many grafts occlude without sequela because of competitive flow from native arteries with functionally nonsignificant lesions. Whether patients with incomplete revascularization documented by 1-year post-CABG angiography have increased long-term morbidity or mortality is unclear and requires further study.
The rate of residual ≥70% coronary stenoses in native vessels, which were either not bypassed or were supplied by an occluded graft, was no different between the angina and no-angina groups. Whether these lesions were functionally significant was not determined in this study. As reported in the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation study, 20% of native coronary stenosis between 70% and 90% severity have no evidence of ischemia by fractional flow reserve. 28 There are several important limitations to this study including that as a Veterans Affairs study, the trial's generalizability may be inherently limited. The study's population was 99.9% male, so these results may not be applicable to women. Overall, ROOBY had a 64.3% follow-up angiography rate in 1-year survivors. While there may be a self-selection bias in those who follow-up with coronary angiography, the angiography rate in this study was comparable to other smaller offpump versus on-pump trials and to a larger VA aspirin study where 1-year follow-up angiography rates were 64% to 65%. [29] [30] [31] Another limitation of this study is that whether coronary lesions or graft occlusions were functionally significant, or may have supplied nonviable myocardium, was not determined by either stress testing or fractional flow reserve. Also, about 34% of patients who were screened for the ROOBY study were excluded for small or diffusely diseased target vessels; so the results may not be applicable to patients with diffuse disease. Given that this study was a retrospective analysis of data gathered during a prospective randomized controlled trial, factors other than those noted above may have impacted the study outcomes.
In conclusion, this ROOBY study subanalysis evaluated the relationship between clinical and 1-year angiographic findings and patient self-reported angina after CABG. Clinical characteristics significantly associated with angina symptoms after CABG were younger age, worse baseline SAQ-AF score, active smoking, diabetes mellitus, and pre-CABG depression. The only 1-year post-CABG angiographic finding significantly associated with angina was revascularization status of the LAD territory. The results of this study should be kept in mind when counseling patients on expected improvements in angina symptoms after CABG. The results also underscore the fact that comorbidities, as much as anatomic considerations, affect the presence of ongoing self-reported angina symptoms after CABG. 
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